Silvio  Dolabella

Dr. Silvio Dolabella

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Microbial Drug Resistance
Verified
Journal Article
Closed access
RVRoberto Vivas
Roberto Vivas
ABAna Andréa Teixeira Barbosa
Ana Andréa Teixeira Barbosa
SDSilvio Dolabella
Silvio Dolabella
SJSona Jain
Sona Jain
Antibiotic resistance is one of the greatest challenges in the health system nowadays, representing a serious problem for public health. Initially, antibiotic-resistant strains were restricted to the hospital environment, but now they can be found everywhere. Globalization, excessive use of antibiotics in animal husbandry and aquaculture, use of multiple broad-spectrum agents, and lack of good antimicrobial stewardship can be listed as the factors most responsible for the spread of antibiotic resistance. The increase in the prevalence of antibiotic-resistant pathogens implies having fewer antimicrobial agents to treat infections. The estimate is that by 2050, there will be no effective antibiotic available, if no new drug is developed or discovered. This raises the need to search for alternative methods of controlling antibiotic-resistant pathogens. Considering this problem, the objective of this review is to outline the most frequent antibiotic-resistant bacteria and describe the advantageous and limitations of alternative methods that have been proposed to control them.

1 June 2001 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DFDorothéa S França
Dorothéa S França
ASAdriano L.S Souza
Adriano L.S Souza
KAKarine R Almeida
Karine R Almeida
SDSilvio Dolabella
Silvio Dolabella
CMCelso Martinelli
Celso Martinelli
MCMárcio M Coelho
Márcio M Coelho

CXCecilia Ximénez
Cecilia Ximénez
RCRene Cerritos
Rene Cerritos
LRLiliana Rojas-Velázquez
Liliana Rojas-Velázquez
SDSilvio Dolabella
Silvio Dolabella
PMPatricia Morán
Patricia Morán
ESEdwards F. Silva
Edwards F. Silva
For over 30 years it has been established that the Entamoeba histolytica protozoan included two biologically and genetically different species, one with a pathogenic phenotype called E. histolytica and the other with a non-pathogenic phenotype called Entamoeba dispar. Both of these amoebae species can infect humans. E. histolytica has been considered as a potential pathogen that can cause serious damage to the large intestine (colitis, dysentery) and other extraintestinal organs, mainly the liver (amebic liver abscess), whereas E. dispar is a species that interacts with humans in a commensal relationship, causing no symptoms or any tissue damage. This paradigm, however, should be reconsidered or re-evaluated. In the present work, we report the detection and genotyping of E. dispar sequences of DNA obtained from patients with amebic liver abscesses, including the genotyping of an isolate obtained from a Brazilian patient with a clinical diagnosis of intestinal amebiasis that was previously characterized as an E. dispar species. The genetic diversity and phylogenetic analysis performed by our group has shown the existence of several different genotypes of E. dispar that can be associated to, or be potentiality responsible for intestinal or liver tissue damage, similar to that observed with E. histolytica.

1 January 2012 in Annals of Hepatology
Verified
Journal Article
Open access
SDSilvio Dolabella
Silvio Dolabella
JSJesús Serrano-Luna
Jesús Serrano-Luna
FNFernando Navarro-García
Fernando Navarro-García
RCRené Cerritos
René Cerritos
CXCecilia Ximénez
Cecilia Ximénez
MSMineko Shibayama
Mineko Shibayama

16 May 2017 in Molecules
Verified
Journal Article
Open access
PDF file
ASAudrey R. S. T. Silva
Audrey R. S. T. Silva
RSRicardo Scher
Ricardo Scher
FSFlaviane V. Santos
Flaviane V. Santos
SFSebastião R. Ferreira
Sebastião R. Ferreira
SCSócrates C. H. Cavalcanti
Sócrates C. H. Cavalcanti
SDSilvio Dolabella
Silvio Dolabella
Several constituents of essential oils have been shown to be active against pathogens such as bacteria, fungi, and protozoa. This study demonstrated the in vitro action of ten compounds present in essential oils against Leishmania amazonensis promastigotes. With the exception of p-cymene, all evaluated compounds presented leishmanicidal activity, exhibiting IC50 between 25.4 and 568.1 μg mL−1. Compounds with the best leishmanicidal activity presented a phenolic moiety (IC50 between 25.4 and 82.9 μg mL−1). Alicyclic alcohols ((−)-menthol and isoborneol) and ketones ((−)-carvone) promoted similar activity against the parasite (IC50 between 190.2 and 198.9 μg mL−1). Most of the compounds showed low cytotoxicity in L929 fibroblasts. Analysis of the structure-activity relationship of these compounds showed the importance of the phenolic structure for the biological action against the promastigote forms of the parasite.

1 February 2008 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
AMAline L. Menezes
Aline L. Menezes
VLVítor M.P. Lima
Vítor M.P. Lima
MFMayrce T.S. Freitas
Mayrce T.S. Freitas
MRMíriam O. Rocha
Míriam O. Rocha
ESEdward F. Silva
Edward F. Silva
SDSilvio Dolabella
Silvio Dolabella
The objective of this study was to verify the occurrence of intestinal parasites in 3 to 6-year-old children from daycare centers maintained by the municipal government of Belo Horizonte, Minas Gerais, Brazil. Coproparasitological tests performed in 472 children have shown that 24.6% of them had some type of parasites, 6.6% of the children having more than one type. Among protozoa, Entamoeba coli (14.0%) and G. duodenalis (9.5%) were the most prevalent, whereas Ascaris lumbricoides (3.0%) and Trichuris trichiura (1.1%) were the most frequent among the helminths. Thus, we can observe that intestinal parasites still represent a serious public health problem in Belo Horizonte, especially among children and in areas where the socioeconomic conditions are less favorable.